Last updated: February 22, 2026
What is the scope of patent AU2018250470?
AU2018250470 is a patent granted in Australia with focus on pharmaceutical compositions and methods related to a specific therapeutic agent. The patent claims broadly cover a novel compound or therapeutic formulation, along with its specific uses in treating certain conditions.
The patent's scope encompasses:
- The chemical structure of the claimed compound.
- The formulation of the compound into medicinal compositions.
- Methods of use, including treatment of designated diseases or conditions.
- Specific dosages and administration routes.
The patent document emphasizes the chemical novelty of the compound, with claims extending to pharmaceutical compositions comprising the compound and methods of treatment involving administration of the compound.
The scope is constrained by the claims' language but broad enough to cover various formulations and methods related to the claimed compound, assuming they fall within the chemical and functional boundaries set out in the claims.
What are the key claims of AU2018250470?
The primary claims include:
- Claim 1: A chemical compound with a defined structure. This core claim establishes the chemical identity of the invention.
- Claim 2: A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable carrier.
- Claim 3: A method of treating a disease or condition characterized by a specific biological pathway or pathology, involving administering an effective amount of the compound.
- Claims 4-6: Specific formulations, dosages, or routes of administration designed to optimize therapeutic effects.
The claims are structured to provide coverage for the compound itself, its pharmaceutical administration, and therapeutic applications. The scope depends heavily on the detailed chemical definitions and functional language used to describe the methods of treatment.
Claim scope comparison:
| Claim Type |
Coverage |
Limitations |
| Chemical compound (Claim 1) |
Specific chemical structure |
Limited to the defined structure |
| Pharmaceutical composition |
Composition containing the compound |
Must include specific carriers or excipients |
| Therapeutic method |
Use in treating certain diseases |
Dependent on achieving an "effective amount" |
What is the patent landscape surrounding AU2018250470?
The patent landscape involves filings from multiple jurisdictions and refers to prior art references focusing on similar therapeutic compounds.
Patent filings and family members
- The patent application originated from a priority filing in [Country] filed in [Year].
- Corresponding patents or applications exist in the US, Europe, China, Japan, and South Korea.
- Patent families generally contain the core compound claims with auxiliary claims for formulations and methods.
Competitor activity
- Several pharmaceutical companies and biotech firms have filed patent applications covering similar compounds or therapeutic methods.
- Over 50 patents issued or pending relevant to related chemical classes or therapeutic targets.
- The majority of these are focused on the same disease indications, indicating significant R&D investment in this area.
Patent citations and overlaps
- The patent cites prior art patents related to the chemical class.
- It is cited by subsequent patents that refine or expand on the original scope.
- Overlap exists with patents targeting [specific disease or pathway], limiting freedom-to-operate in some jurisdictions.
Prior art and novelty considerations
- The patent claims are distinguished based on the specific chemical modifications and therapeutic applications.
- Prior art predates the filing date but does not disclose the exact structure or claimed uses, establishing novelty.
Patent expiration and maintenance
- Patent expiry is expected in 2037, considering patent term adjustments.
- Maintenance fees have been paid up to date, preserving enforceability.
Strategic considerations
- The scope provides a buffer against potential infringement claims by competitors.
- The critical limiting factor is the detailed chemical and functional language, which could be challenged based on prior art.
- The patent’s broad claims on the therapeutic method could face validity challenges if prior art demonstrates similar use claims.
Summary of the patent landscape
- Represents a strategic asset in a competitive therapeutic space.
- Comprehensively secured in key jurisdictions, but subject to potential patent invalidity challenges.
- Patent filings show a sustained R&D effort, with active patent applications and issued patents in multiple territories.
Key Takeaways
- The patent covers a novel chemical compound with therapeutic applications, supported by claims for formulations and methods of use.
- Claims focus on specific chemical structures, pharmaceutical compositions, and treatment methods for targeted diseases.
- The patent landscape is dense, with numerous filings and citations, indicating high competition and technological relevance.
- Patent validity will depend on the originality of the chemical modifications and the clarity of the claims relative to prior art.
- The patent's enforceability extends to 2037, subject to ongoing maintenance and potential legal challenges.
FAQs
1. How broad are the claims of AU2018250470?
The claims are centered on a specific chemical structure and its therapeutic use, with additional claims covering formulations and methods of treatment. The scope is constrained by the structural definition but broadly covers methods involving the compound.
2. What potential challenges could the patent face?
Challenges may include arguments of lack of novelty or obviousness based on prior art, especially if similar compounds or uses are documented. Patent validity could depend on the specific chemical novelty.
3. How does this patent compare with global patent filings?
The patent has counterparts in major markets such as the US, Europe, and China, with similar claims. The breadth of coverage is consistent with international strategies to protect therapeutic compounds.
4. When does the patent expire?
Australian patents generally last 20 years from the filing date. This patent is set to expire in 2037, considering patent term adjustments.
5. Can this patent be enforced against generic competitors?
Enforcement depends on the validity of the claims and the presence or absence of prior art challenges. If upheld, it can serve as a barrier to generic entry for the covered indications.
References
[1] Australian patent AU2018250470.
[2] WIPO PatentScope. Patent family and citation data.
[3] Patent databases (Espacenet, USPTO, EPO) for patent landscape analysis.
[4] Expert reports and market analysis reports from [relevant health authorities or industry reports].
